Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 203 participants.
Also called NCT02664155
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 203 participants
- Registry
-
NCT02664155 -
2016-000858-35
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Terminated
Technical summary
Registry record NCT02664155. Randomized; no masking; primary purpose treatment. Start 2016-10-19 (actual); primary completion 2021-11-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
- Acronym
- VERDICT
- Condition
- Renal Insufficiency
- Intervention (Drug)
- Apixaban
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- Heparin
- Intervention (Drug)
- VKA
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Collaborator
- Ministry of Health, France
Record details
- Record id
cardio:ct-nct02664155- Content hash
d11f615d5a4cc6811b9624616ad297817df6c269a2cd5405a8fa880ed18b61cc